Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease. [electronic resource]
- Alzheimer's research & therapy 08 2016
- 34 p. digital
Publication Type: Journal Article
1758-9193
10.1186/s13195-016-0199-5 doi
Alzheimer Disease--drug therapy Amyloid Precursor Protein Secretases--metabolism Amyloid beta-Peptides--metabolism Animals Brain--drug effects Cell Line, Tumor Drug Evaluation, Preclinical HEK293 Cells HeLa Cells Heterocyclic Compounds, 4 or More Rings--pharmacokinetics Humans Male Mice Mice, 129 Strain Mutation Neocortex--drug effects Nootropic Agents--pharmacokinetics Presenilin-1--genetics Rats, Wistar